Lupus News

Cancer screening recommendations for patients with autoimmune diseases largely rely on clinical experience and extrapolation in the absence of abundant data, according to a speaker at the 2021 Congress of Clinical Rheumatology-East meeting.

So-called “COVID toes” and other cutaneous manifestations of the virus are not the only dermatologic challenges that a rheumatologist may face, according to a presenter at the 2021 Congress of Clinical Rheumatology-East.

A thorough physical exam and attention to a patient’s medical history are integral to differentiating dermatomyositis from cutaneous dermatomyositis with similar features, according to a presenter here.

A mounting body of evidence is showing that cognitive dysfunction in lupus is a legitimate complaint, according to a presenter at the 2021 Congress of Clinical Rheumatology-East.

The recent approval of anifrolumab highlights what may be a new wave of therapeutic advances made in lupus, according to a presenter at the 2021 Congress of Clinical Rheumatology-East.

Contrary to Choosing Wisely recommendations, indiscriminate and high use of antinuclear antibodies multiplex testing has fostered widespread unfamiliarity of what it tests for and how to interpret its results, noted a presenter here.

Patients with myasthenia gravis — particularly those post-thymectomy — demonstrate an increased odds for having systemic lupus erythematosus, according to a speaker at the 2021 North American Young Rheumatology Investigator Forum.

Healthy lifestyle behaviors could potentially reduce the risk for systemic lupus erythematosus by nearly half, according to data published in Arthritis & Rheumatology.

Among patients with lupus erythematosus panniculitis resulting from cutaneous lupus erythematosus, male sex and discoid lupus erythematosus were risk factors for systemic lupus erythematosus development, according to a study.

Managing cardiovascular event risk is critical to preventing morbidity and mortality in lupus nephritis, especially among groups at increased risk for the disease, according to a speaker at the 2021 Rheumatology Nurses Society annual conference.